A panel of FDA advisers is currently reviewing a new multicancer-detection test, a move that could pave the way for Medicare coverage in the near future. The evaluation represents a significant step toward broader access to early cancer screening technologies, though decisions regarding reimbursement remain contingent on the outcome of this federal assessment.
FDA Advisory Panel Reviews Multicancer Blood Test as Medicare Coverage Looms
Medicare coverage would be a game changer, but I wonder how long the approval process will actually take.
This is a massive leap for early detection. Finally, a screening tool that can catch multiple cancers at once.